- Citations, last 5 years
- 6 675
- Works, last 5 years
- 1 109
- h-index
- 290
- Scientists listed
- 163
- Grants since 2016
- 653
Grants received
2016–2019 · contract · N01
IGF::OT::IGF BIOEQUIVALENCY STUDIES
Stephen Stern · Leidos (United States) · funded by National Institutes of Health
2016–2021 · contract · N01
Research, Development and Production to Support Clinical Trials for HIV Vaccines
David Lindsay · Leidos (United States) · funded by National Institutes of Health
2016–2018 · contract · N01
IGF::OT::IGF BLDG. 538- 1ST FLOOR REFURBISHMENT AND INFRASTRUCTURE
Robillard Craig · Leidos (United States) · funded by National Institutes of Health
2016–2020 · contract · N01
IGF::OT::IGF RESEARCH, DEVELOPMENT, PRODUCTION AND SUPPORT FOR CLINICAL TRIALS BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES (BNMABS)
Matt Westerman · Leidos (United States) · funded by National Institutes of Health
2016–2021 · contract · N01
IGF::OT::IGF RESEARCH, DEVELOPMENT, MANUFACTURE OF CLINICAL MATERIALS, AND CLINICAL TESTING OF VACCINES TO PROTECT AGAINST ZIKA VIRUS
Theresa Engel · Leidos (United States) · funded by National Institutes of Health
2016–2021 · contract · N01
IGF::OT::IGF DCTD TUMOR TISSUE ACQUISITION
Ralph Parchment · Leidos (United States) · funded by National Institutes of Health
2016–2018 · contract · N01
IGF::OT::IGF BIOEQUIVALENCY STUDIES
Stephen Stern · Leidos (United States) · funded by National Institutes of Health
2016–2018 · contract · N01
IGF::OT::IGF BLDG. 433- NORTH REFURBISHMENT & BLDG. 433- INFRASTRUCTURE
Ryan Ireland · Leidos (United States) · funded by National Institutes of Health
2016–2021 · contract · N01
IGF::OT::IGF GENOMIC CHARACTERIZATION CENTERS FOR NCI-MATCH
Linda Hannick · Leidos (United States) · funded by National Institutes of Health
2016–2019 · contract · N02
BLDG. 538- 1ST FLOOR REFURBISHMENT AND INFRASTRUCTURE
Robillard Craig · Leidos (United States) · funded by National Institutes of Health
2015–2021 · contract · N01
EBOLA VIRUS AND OTHER EMERGING & RE-EMERGING INFECTIOUS DISEASES
Elizabeth Baseler · Leidos (United States) · funded by National Institutes of Health
2015–2020 · contract · N01
IGF::OT::IGF OPERATION OF GOVERNMENT-OWNED CONTRACTOR-OPERATED (GOCO) R&D FACILITIES
John Beigel · Leidos (United States) · funded by National Institutes of Health
2015–2020 · contract · N01
IGF::OT::IGF NS IDIQ: VIRAL AND HEMORRHAGIC FEVERS: EBOLA
Beth Baseler · Leidos (United States) · funded by National Institutes of Health
2015–2020 · contract · N01
TUBERCULOSIS VACCINE DEVELOPMENT
Christopher Case · Leidos (United States) · funded by National Institutes of Health
2015–2020 · contract · N01
MOLECULAR ANALYSIS OF TUMORS FOR TREATMENT SELECTION IN CLINICAL TRIALS- PHASE II
Joyann Phillips Rohan · Leidos (United States) · funded by National Institutes of Health
2015–2021 · contract · N01
Lung Cancer Multiple Reaction Monitoring Project
William Bocik · Leidos (United States) · funded by National Institutes of Health
2015–2020 · contract · N01
ADVANCE CHIKUNGUNYA VACCINE CANDIDATES INTO LATER-PHASE CLINICAL TRIALS
Matt Westerman · Leidos (United States) · funded by National Institutes of Health
2015–2020 · contract · N01
RESPIRATORY VIRUSES RESEARCH
John Beigel · Leidos (United States) · funded by National Institutes of Health
2015–2020 · contract · N01
MALARIA VACCINE EVALUATION
Christopher Case · Leidos (United States) · funded by National Institutes of Health
2015–2021 · contract · N01
EBOLA VIRUS AND OTHER EMERGING & RE-EMERGING INFECTIOUS DISEASES
Elizabeth Baseler · Leidos (United States) · funded by National Institutes of Health
2015–2021 · contract · N01
Molecular characterization and clinical assay development program
Mickey Williams · Leidos (United States) · funded by National Institutes of Health
2015–2020 · contract · N01
IGF::OT::IGF HIV CLINICAL RESEARCH IN WEST AFRICA
Laurie Lambert · Leidos (United States) · funded by National Institutes of Health
2015–2020 · contract · N01
IGF::OT::IGF HIV CLINICAL RESEARCH IN WEST AFRICA
Laurie Lambert · Leidos (United States) · funded by National Institutes of Health
2015–2020 · contract · N01
ADVANCE CHIKUNGUNYA VACCINE CANDIDATES INTO LATER-PHASE CLINICAL TRIALS
Matt Westerman · Leidos (United States) · funded by National Institutes of Health
2015–2020 · contract · N02
MOLECULAR ANALYSIS OF TUMORS FOR TREATMENT SELECTION IN CLINICAL TRIALS- PHASE II
Joyann Phillips Rohan · Leidos (United States) · funded by National Institutes of Health
2015–2020 · contract · N01
IGF::OT::IGF NS IDIQ: OPERATIONS AND TECHNICAL SUPPORT (OTS) FOR THE FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH (FNLCR), A FEDERALLY FUNDED RESEARCH AND DEVELOPMENT CENTER (FFRDC)
George Mitra · Leidos (United States) · funded by National Institutes of Health
2015–2020 · contract · N01
Human Cancer Models Initiative
Ellen Miller · Leidos (United States) · funded by National Institutes of Health
2015–2020 · contract · N01
Human Cancer Models Initiative
Ellen Miller · Leidos (United States) · funded by National Institutes of Health
2015–2021 · contract · N01
Molecular characterization and clinical assay development program
Mickey Williams · Leidos (United States) · funded by National Institutes of Health
2015–2021 · contract · N01
Lung Cancer Multiple Reaction Monitoring Project
William Bocik · Leidos (United States) · funded by National Institutes of Health
2015–2020 · contract · N01
IGF::OT::IGF ADVANCE UNIVERSAL INFLUENZA VACCINE CANDIDATES BASED ON RBD-FERRITIN NANOPARTICLES
Matt Westerman · Leidos (United States) · funded by National Institutes of Health
2015–2021 · contract · N01
IGF::OT::IGF OPERATION OF GOVERNMENT-OWNED CONTRACTOR-OPERATED (GOCO) R&D FACILITIES
William Bocik · Leidos (United States) · funded by National Institutes of Health
2015–2020 · contract · N01
MOLECULAR ANALYSIS OF TUMORS FOR TREATMENT SELECTION IN CLINICAL TRIALS- PHASE II
Joyann Phillips Rohan · Leidos (United States) · funded by National Institutes of Health
2015–2020 · contract · N01
TUBERCULOSIS VACCINE DEVELOPMENT
Christopher Case · Leidos (United States) · funded by National Institutes of Health
2015–2020 · contract · N01
Development and Production of membrane Proximal External Region (MPER)/ Anti-HIV broadly neutralizing antibodies (bNAbs) for prevention, therapy or cure
Matt Westerman · Leidos (United States) · funded by National Institutes of Health
2015–2020 · contract · N01
IGF::OT::IGF OPERATION OF GOVERNMENT-OWNED CONTRACTOR-OPERATED (GOCO) R&D FACILITIES
John Beigel · Leidos (United States) · funded by National Institutes of Health
2015–2021 · contract · N01
Lung Cancer Multiple Reaction Monitoring Project
William Bocik · Leidos (United States) · funded by National Institutes of Health
2011–2021 · contract · N01
NIAID Biopharmaceutical Product Development Services
Casey Koontz · Leidos (United States) · funded by National Institutes of Health
2011–2021 · contract · N01
TASK 17: Manufacture of mAb Clinical Material
Casey Koontz · Leidos (United States) · funded by National Institutes of Health
2011–2021 · contract · N01
TASK X12: THERAPEUTICS FOR NOROVIRUS
Casey Koontz · Leidos (United States) · funded by National Institutes of Health